Dan‐Arin Silasi

5.5k total citations
85 papers, 3.0k citations indexed

About

Dan‐Arin Silasi is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Dan‐Arin Silasi has authored 85 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 30 papers in Obstetrics and Gynecology and 25 papers in Reproductive Medicine. Recurrent topics in Dan‐Arin Silasi's work include Uterine Myomas and Treatments (22 papers), Ovarian cancer diagnosis and treatment (21 papers) and Endometrial and Cervical Cancer Treatments (19 papers). Dan‐Arin Silasi is often cited by papers focused on Uterine Myomas and Treatments (22 papers), Ovarian cancer diagnosis and treatment (21 papers) and Endometrial and Cervical Cancer Treatments (19 papers). Dan‐Arin Silasi collaborates with scholars based in United States, Italy and Australia. Dan‐Arin Silasi's co-authors include Thomas Rutherford, Gil Mor, Ayesha B. Alvero, Peter E. Schwartz, Irene Visintin, Masoud Azodi, Alessandro D. Santin, Rui Chen, Michael Kelly and Han‐Hsuan Fu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Dan‐Arin Silasi

84 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan‐Arin Silasi United States 30 1.2k 1.1k 747 680 591 85 3.0k
Hanbyoul Cho South Korea 26 1.1k 0.9× 1.2k 1.1× 598 0.8× 504 0.7× 362 0.6× 94 2.7k
Beihua Kong China 32 611 0.5× 1.2k 1.1× 685 0.9× 487 0.7× 1.2k 2.0× 121 3.1k
Ivo Meinhold‐Heerlein Germany 27 528 0.4× 800 0.7× 407 0.5× 384 0.6× 956 1.6× 133 2.5k
Ryusuke Murakami Japan 19 1.2k 1.1× 606 0.5× 393 0.5× 952 1.4× 450 0.8× 78 2.3k
Kaoru Abiko Japan 25 2.4k 2.0× 965 0.9× 557 0.7× 1.8k 2.7× 697 1.2× 102 4.0k
Masafumi Koshiyama Japan 24 602 0.5× 699 0.6× 266 0.4× 400 0.6× 883 1.5× 81 2.0k
Yasunobu Kanamori Japan 26 1.1k 0.9× 1.0k 0.9× 452 0.6× 130 0.2× 573 1.0× 72 2.5k
Jesús González Bosquet United States 23 392 0.3× 724 0.6× 460 0.6× 175 0.3× 530 0.9× 100 1.9k
Ryuichi Kudo Japan 29 483 0.4× 1.1k 0.9× 600 0.8× 204 0.3× 845 1.4× 98 2.8k
Wenxin Zheng United States 39 667 0.6× 1.4k 1.2× 607 0.8× 614 0.9× 2.1k 3.6× 201 4.6k

Countries citing papers authored by Dan‐Arin Silasi

Since Specialization
Citations

This map shows the geographic impact of Dan‐Arin Silasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan‐Arin Silasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan‐Arin Silasi more than expected).

Fields of papers citing papers by Dan‐Arin Silasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan‐Arin Silasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan‐Arin Silasi. The network helps show where Dan‐Arin Silasi may publish in the future.

Co-authorship network of co-authors of Dan‐Arin Silasi

This figure shows the co-authorship network connecting the top 25 collaborators of Dan‐Arin Silasi. A scholar is included among the top collaborators of Dan‐Arin Silasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan‐Arin Silasi. Dan‐Arin Silasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jessel, Shlomit, Ayesha B. Alvero, Dan‐Arin Silasi, et al.. (2021). Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer. Cancers. 13(2). 325–325. 4 indexed citations
2.
Kyriakides, Tassos C., et al.. (2020). Laparoscopic Posterior Versus Lateral Transversus Abdominis Plane Block in Gynecology. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 24(3). e2020.00032–e2020.00032.
3.
Albright, Benjamin B., Jonathan D. Black, Stefan Gysler, et al.. (2018). Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer. Gynecologic Oncology Reports. 23. 28–33. 3 indexed citations
4.
Menderes, Gulden, Elena Bonazzoli, Stefania Bellone, et al.. (2017). Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo. Medical Oncology. 34(5). 91–91. 15 indexed citations
5.
Menderes, Gulden, et al.. (2017). Robotic Resection of a Symptomatic Parasitic Leiomyoma From the Obturator Fossa. Journal of Minimally Invasive Gynecology. 25(1). 23–23. 7 indexed citations
6.
Alvero, Ayesha B., Andrew Heaton, Mary Pitruzzello, et al.. (2016). TRX-E-002-1 Induces c-Jun–Dependent Apoptosis in Ovarian Cancer Stem Cells and Prevents Recurrence In Vivo. Molecular Cancer Therapeutics. 15(6). 1279–1290. 21 indexed citations
7.
Ferrari, Francesca, Stefania Bellone, Jonathan Black, et al.. (2015). Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro. Journal of Experimental & Clinical Cancer Research. 34(1). 123–123. 31 indexed citations
8.
Schwab, Carlton L., Diana P. English, Jonathan Black, et al.. (2015). Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo. Gynecologic Oncology. 139(1). 112–117. 26 indexed citations
9.
Lopez, Salvatore, Emiliano Cocco, Jonathan Black, et al.. (2015). Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo. Molecular Cancer Therapeutics. 14(11). 2519–2526. 26 indexed citations
10.
Bellone, Stefania, Floriana Centritto, Jonathan Black, et al.. (2015). Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients. Gynecologic Oncology. 138(1). 11–17. 61 indexed citations
11.
Craveiro, Vinicius, Yang Yang‐Hartwich, Jennie C. Holmberg, et al.. (2013). Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment. Cancer Medicine. 2(6). 987–987. 7 indexed citations
12.
Solomon, Daniel, Amir Hafeez Shariff, Dan‐Arin Silasi, et al.. (2012). Transvaginal cholecystectomy versus single-incision laparoscopic cholecystectomy versus four-port laparoscopic cholecystectomy: a prospective cohort study. Surgical Endoscopy. 26(10). 2823–2827. 35 indexed citations
13.
Yu, Herbert, Thomas Rutherford, Masoud Azodi, et al.. (2012). Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV). Journal of Surgical Oncology. 107(2). 195–200. 46 indexed citations
15.
Roberts, Kurt E., Daniel Solomon, Tamar L. Mirensky, et al.. (2011). Pure Transvaginal Appendectomy Versus Traditional Laparoscopic Appendectomy for Acute Appendicitis. Annals of Surgery. 255(2). 266–269. 32 indexed citations
16.
Roberts, Kurt E., et al.. (2011). Transvaginal NOTES Hybrid Cholecystectomy. Surgical Innovation. 19(3). 230–235. 18 indexed citations
17.
Silasi, Dan‐Arin, et al.. (2011). Chronic Hypertrophic Vulvar Herpes Simulating Neoplasia. International Journal of Gynecological Pathology. 31(1). 33–37. 4 indexed citations
18.
ElSahwi, Karim, Jessica L. Illuzzi, Joyce Varughese, et al.. (2011). A survey of gynecologic oncologists regarding the End-of-Life discussion: A pilot study. Gynecologic Oncology. 124(3). 471–473. 18 indexed citations
19.
Richter, C., Emiliano Cocco, Stefania Bellone, et al.. (2010). High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody. American Journal of Obstetrics and Gynecology. 203(6). 582.e1–582.e7. 29 indexed citations
20.
Richter, C., Pei Hui, Natália Buza, et al.. (2010). HER-2/NEU overexpression in vulvar Paget disease: the Yale experience. Journal of Clinical Pathology. 63(6). 544–547. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026